Definitive Healthcare (DH) Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last year. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DH shares.
View DH analyst ratings or view top-rated stocks.

8 brokerages have issued 1-year price targets for Definitive Healthcare's shares. Their DH share price forecasts range from $10.00 to $15.50. On average, they anticipate the company's stock price to reach $12.69 in the next twelve months. This suggests a possible upside of 60.8% from the stock's current price.
View analysts price targets for DH or view top-rated stocks among Wall Street analysts.

Definitive Healthcare's stock was trading at $10.99 on January 1st, 2023. Since then, DH shares have decreased by 28.2% and is now trading at $7.89.
View the best growth stocks for 2023 here.

Definitive Healthcare saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 6,400,000 shares, a decline of 31.9% from the August 15th total of 9,400,000 shares. Based on an average daily volume of 648,600 shares, the days-to-cover ratio is presently 9.9 days. Currently, 16.8% of the shares of the stock are sold short.
View Definitive Healthcare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our DH earnings forecast.

Definitive Healthcare Corp. (NASDAQ:DH) announced its quarterly earnings results on Monday, August, 14th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. The business earned $60.96 million during the quarter, compared to the consensus estimate of $61 million. Definitive Healthcare had a positive trailing twelve-month return on equity of 0.29% and a negative net margin of 5.31%. The business's quarterly revenue was up 11.7% on a year-over-year basis. During the same period in the previous year, the business earned ($0.01) earnings per share.

ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Alger Weatherbie Enduring Growth ETF (AWEG), Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

Definitive Healthcare updated its third quarter 2023 earnings guidance on Monday, August, 14th. The company provided earnings per share guidance of $0.05-$0.07 for the period, compared to the consensus estimate of $0.05. The company issued revenue guidance of $63.00 million-$64.50 million, compared to the consensus revenue estimate of $64.24 million.

(DH) raised $350 million in an initial public offering (IPO) on Wednesday, September 15th 2021. The company issued 15,555,555 shares at $21.00-$24.00 per share.

Definitive Healthcare trades on the NASDAQ under the ticker symbol "DH."

Definitive Healthcare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (4.94%), JPMorgan Chase & Co. (4.62%), Brown Advisory Inc. (3.58%), BlackRock Inc. (3.38%), Riverbridge Partners LLC (2.63%) and Clearbridge Investments LLC (2.06%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc.
View institutional ownership trends.

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DH stock can currently be purchased for approximately $7.89.

Definitive Healthcare (NASDAQ:DH) has a market capitalization of $893.94 million and generates $222.65 million in revenue each year. The company earns $-7,220,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis.

The company employs 946 workers across the globe.

Definitive Healthcare's mailing address is 550 COCHITUATE ROAD, FRAMINGHAM MA, 01701. The official website for the company is www.definitivehc.com. The company can be reached via phone at 508-720-4224 or via email at ir@definitivehc.com.